G9a, a multipotent regulator of gene expression SR Shankar, AG Bahirvani, VK Rao, N Bharathy, JR Ow, R Taneja Epigenetics 8 (1), 16-22, 2013 | 208 | 2013 |
Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation BMT Ling, N Bharathy, TK Chung, WK Kok, SD Li, YH Tan, VK Rao, ... Proceedings of the National Academy of Sciences 109 (3), 841-846, 2012 | 186 | 2012 |
Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor R Modak, J Basha, N Bharathy, K Maity, P Mizar, AV Bhat, M Vasudevan, ... ACS chemical biology 8 (6), 1311-1323, 2013 | 68 | 2013 |
The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma N Bharathy, NE Berlow, E Wang, J Abraham, TP Settelmeyer, JE Hooper, ... Science signaling 11 (557), eaau7632, 2018 | 66 | 2018 |
Epigenetic regulation of skeletal muscle development and differentiation N Bharathy, BMT Ling, R Taneja Epigenetics: Development and Disease, 139-150, 2013 | 62 | 2013 |
Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism JLY Yap, YK Tai, J Fröhlich, CHH Fong, JN Yin, ZL Foo, S Ramanan, ... The FASEB Journal 33 (11), 12853, 2019 | 60 | 2019 |
G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation VK Rao, JR Ow, SR Shankar, N Bharathy, J Manikandan, Y Wang, ... Nucleic acids research 44 (17), 8129-8143, 2016 | 55 | 2016 |
G9a mediates Sharp-1–dependent inhibition of skeletal muscle differentiation BMT Ling, S Gopinadhan, WK Kok, SR Shankar, P Gopal, N Bharathy, ... Molecular biology of the cell 23 (24), 4778-4785, 2012 | 53 | 2012 |
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma N Bharathy, MN Svalina, TP Settelmeyer, MM Cleary, NE Berlow, ... Oncotarget 8 (38), 62976, 2017 | 27 | 2017 |
P/CAF mediates PAX3–FOXO1‐dependent oncogenesis in alveolar rhabdomyosarcoma N Bharathy, S Suriyamurthy, VK Rao, JR Ow, HJ Lim, P Chakraborty, ... The Journal of pathology 240 (3), 269-281, 2016 | 27 | 2016 |
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma N Bharathy, NE Berlow, E Wang, J Abraham, TP Settelmeyer, JE Hooper, ... Skeletal Muscle 9, 1-10, 2019 | 25 | 2019 |
Volasertib preclinical activity in high-risk hepatoblastoma D Kats, CA Ricker, NE Berlow, B Noblet, D Nicolle, K Mevel, ... Oncotarget 10 (60), 6403, 2019 | 23 | 2019 |
G9a inhibits MEF2C activity to control sarcomere assembly JR Ow, M Palanichamy Kala, VK Rao, MH Choi, N Bharathy, R Taneja Scientific Reports 6 (1), 34163, 2016 | 20 | 2016 |
Defining the extracellular matrix of rhabdomyosarcoma X Lian, JS Bond, N Bharathy, SP Boudko, E Pokidysheva, JF Shern, ... Frontiers in oncology 11, 601957, 2021 | 15 | 2021 |
Methylation muscles into transcription factor silencing N Bharathy, R Taneja Transcription 3 (5), 215-220, 2012 | 15 | 2012 |
SMARCA4 biology in alveolar rhabdomyosarcoma N Bharathy, MM Cleary, JA Kim, K Nagamori, KA Crawford, E Wang, ... Oncogene 41 (11), 1647-1656, 2022 | 12 | 2022 |
In vitro benchmarking of NF-κB inhibitors AP Harrold, MM Cleary, N Bharathy, M Lathara, NE Berlow, NK Foreman, ... European journal of pharmacology 873, 172981, 2020 | 12 | 2020 |
Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma D Beltrán, ME Anderson, N Bharathy, TP Settelmeyer, MN Svalina, ... Skeletal Muscle 9, 1-10, 2019 | 10 | 2019 |
Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1 JA Kim, NE Berlow, M Lathara, N Bharathy, LR Martin, R Purohit, ... Biochemical and Biophysical Research Communications 621, 101-108, 2022 | 4 | 2022 |
Interleukin-4 receptor inhibition targeting metastasis independent of macrophages MM Cleary, N Bharathy, J Abraham, JA Kim, ER Rudzinski, JE Michalek, ... Molecular cancer therapeutics 20 (5), 906-914, 2021 | 3 | 2021 |